INMD Inmode Ltd
- Stocks
- Healthcare
- NASDAQ: INMD
Price (delayed)
$14.35
Market cap
$907.67M
P/E Ratio
5.76
Dividend/share
N/A
EPS
$2.49
Enterprise value
$697.53M
inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and
Highlights
The price to earnings (P/E) is 67% less than the 5-year quarterly average of 17.2 and 22% less than the last 4 quarters average of 7.4
The EPS is up by 40% year-on-year and by 6% since the previous quarter
The gross profit has declined by 6% year-on-year but it is up by 2.3% since the previous quarter
INMD's revenue is down by 3.6% year-on-year but it is up by 2.3% since the previous quarter
Inmode's equity has decreased by 16% YoY
The company's debt rose by 9% QoQ and by 8% YoY
Key stats
What are the main financial stats of INMD
Market
Valuations
Earnings
Shares outstanding
63.25M
Market cap
$907.67M
Enterprise value
$697.53M
Price to earnings (P/E)
5.76
Price to book (P/B)
1.57
Price to sales (P/S)
2.26
EV/EBIT
4.85
EV/EBITDA
4.83
EV/Sales
1.74
Revenue
$401.56M
Gross profit
$321.18M
Operating income
$114.62M
Net income
$178.7M
EBIT
$143.81M
EBITDA
$144.56M
Free cash flow
$103.99M
Per share
Balance sheet
Liquidity
EPS
$2.49
EPS diluted
$2.47
Free cash flow per share
$1.64
Book value per share
$9.14
Revenue per share
$6.35
TBVPS
$11.2
Total assets
$708.35M
Total liabilities
$79.91M
Debt
$6.1M
Equity
$628.44M
Working capital
$572.25M
Debt to equity
0.01
Current ratio
9.6
Quick ratio
8.25
Net debt/EBITDA
-1.45
Margins
Efficiency
Dividend
EBITDA margin
36%
Gross margin
80%
Net margin
44.5%
Operating margin
28.5%
Return on assets
23.6%
Return on equity
26.6%
Return on invested capital
27.7%
Return on capital employed
22.4%
Return on sales
35.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INMD stock price
How has the Inmode stock price performed over time
Intraday
0.49%
1 week
1.7%
1 month
0.7%
1 year
-10.2%
YTD
-14.07%
QTD
-0.62%
Financial performance
How have Inmode's revenue and profit performed over time
Revenue
$401.56M
Gross profit
$321.18M
Operating income
$114.62M
Net income
$178.7M
Gross margin
80%
Net margin
44.5%
The company's net margin rose by 24% YoY
INMD's net income is up by 20% year-on-year
Inmode's operating income has decreased by 14% YoY but it has increased by 4.1% QoQ
Inmode's operating margin has decreased by 11% YoY
Price vs fundamentals
How does INMD's price correlate with its fundamentals
Growth
What is Inmode's growth rate over time
Valuation
What is Inmode stock price valuation
P/E
5.76
P/B
1.57
P/S
2.26
EV/EBIT
4.85
EV/EBITDA
4.83
EV/Sales
1.74
The price to earnings (P/E) is 67% less than the 5-year quarterly average of 17.2 and 22% less than the last 4 quarters average of 7.4
The EPS is up by 40% year-on-year and by 6% since the previous quarter
INMD's P/B is 72% below its 5-year quarterly average of 5.6 and 13% below its last 4 quarters average of 1.8
Inmode's equity has decreased by 16% YoY
INMD's price to sales (P/S) is 68% lower than its 5-year quarterly average of 7.1 and 25% lower than its last 4 quarters average of 3.0
INMD's revenue is down by 3.6% year-on-year but it is up by 2.3% since the previous quarter
Efficiency
How efficient is Inmode business performance
INMD's return on equity is up by 37% year-on-year and by 6% since the previous quarter
Inmode's ROA has increased by 35% YoY and by 6% from the previous quarter
The return on invested capital rose by 15% since the previous quarter and by 12% year-on-year
The ROS is down by 9% year-on-year
Dividends
What is INMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INMD.
Financial health
How did Inmode financials performed over time
Inmode's total liabilities has decreased by 26% YoY and by 6% from the previous quarter
Inmode's total assets has decreased by 18% YoY
The company's debt is 99% lower than its equity
Inmode's equity has decreased by 16% YoY
The company's debt rose by 9% QoQ and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.